Curevac will Entschädigung von Biontech

Curevac pushes restart

Germany has a strategy problem

US investors rely on German biotech companies

Biontech and Moderna in the expansion race

How our emotions get us out of our money

Curevac is trying to restart staff

Curevac is trying to restart staff